#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuropathy peripheral B-cell small lymphocytic lymphoma Juvenile idiopathic arthritis Primary hyperoxaluria Pneumonia Congenital myopathy Anaplastic large cell lymphoma T- and null-cell types Acute myeloid leukaemia refractory Pseudoxanthoma elasticum Glioblastoma multiforme Ischaemic stroke Eosinophilic oesophagitis Cerebral amyloid angiopathy Epilepsy with myoclonic-atonic seizures Diabetes insipidus More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage III – Diagnostics Urea cycle disorder – Treatment Adrenocortical carcinoma – Trials in Disease Friedreich’s ataxia Glycogen storage disease type I – Life with Disease Atypical haemolytic uraemic syndrome – Diagnostics Choroid melanoma – Treatment Lymphangioma – Diagnostics Combined immunodeficiency Paroxysmal nocturnal haemoglobinuria – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Faricimab Pyridoxine Hydrochloride Bp Pegvaliase Briquilimab Fulvestrant Glycerol Sodium Lactate Istem-01 Peposertib Dersimelagon Phosphate Daunorubicin Ethanol, Anhydrous HUMAN PLASMA VOXVOGANAN Metformin Hydrochloride PETHIDINE HYDROCHLORIDE Arginine Hydrochloride Mesalazine AZD3632 OMTX705 More therapies…

    Learn about Your Condition

    Blood disorder Amyotrophic lateral sclerosis Spermatocele Breast cancer metastatic Adenosquamous cell lung cancer Procedural headache Acute myocardial infarction Congenital ureteric anomaly Malabsorption Urethral valves Peripheral ischaemia Major depression Postprandial hypoglycaemia Malformation venous Neuropathic arthropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Colon cancer

  • Study of 18F-FAPI-74 PET/CT Imaging for Detection of Lymph Node Metastases in Patients with Colon Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • [Al[18F]F]Fapi-74
    Finland

  • Study of CAPOX or FOLFOX chemotherapy before surgery in patients with obstructive colon cancer treated with colostomy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Levoleucovorin
    • Capecitabine
    • Fluorouracil
    France

  • A study of peginterferon alfa-2a to improve immune system function during colon cancer surgery

    Recruiting

    2 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Peginterferon Alfa-2A
    • Sodium Chloride
    Denmark

  • Study on Pre-Surgery Immunotherapy with Relatlimab, Anti-IL-8 mAb, and Ipilimumab for Early-Stage Colon Cancer Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Anti-Il-8 Human Monoclonal Antibody
    • Celecoxib
    • Ipilimumab
    The Netherlands

  • Study on the Effectiveness of Chemotherapy with Folinic Acid, Fluorouracil, and Irinotecan for Patients with Stage III Colon Cancer After Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Tipiracil
    • Trifluridine
    • Bevacizumab
    France

  • Study on the Safety and Feasibility of Bevacizumab-800CW Imaging for Patients with Barrett’s Esophagus, Colon Cancer, or Gastrointestinal Dysplasia

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Barrett’s oesophagus
    • Colon cancer
    Investigated Drugs:
    • Bevacizumab
    The Netherlands
Previous Page
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!